Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants Through a Case Report

Case Reports in Hematology
doi 10.1155/2014/548272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

The Reversal of Direct Oral Anticoagulants in Animal Models

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2017English

Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting

Anesthesiology
AnesthesiologyPain Medicine
2013English

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Cardiogenic Subarachnoid Bleed: A Case Report

2016English

Reversal of Direct Oral Anticoagulants: Guidance From the Anticoagulation Forum

American Journal of Hematology
Hematology
2019English

A New Generation of Oral Direct Anticoagulants

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Reversal of Direct Oral Anticoagulants for Liver Transplantation in Cirrhosis: A Step Forward

Liver Transplantation
HepatologyTransplantationSurgery
2017English

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs
Pharmacology
2014English

Delayed Bleeding After Implant Surgery in Patients Taking Novel Oral Anticoagulants: A Case Report

Journal of Dental Anesthesia and Pain Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy